MeVis Medical Solutions AG

Transaction in Own Shares • Nov 4, 2008

News Details

Ad-hoc | 4 November 2008 20:30

MeVis Medical Solutions AG launching stock buy-back program

MeVis Medical Solutions AG / Share Buyback

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a specialist in
disease-oriented software products for image-based medicine, is launching a
stock buy-back program.

Under a resolution passed at the annual general meeting on July 9, 2008,
the Company is authorized to buy back up to 10 percent of its own current
share capital in accordance with Section 71 (1) Sentence 1 No. 8 of the
German Stock Corporations Act. MeVis Medical Solutions currently holds
91,000 own shares, which accounts for 5 percent of the Company’s share
capital.

The Executive Board decided on November 4, 2008 to buy back a further
volume of up to 91,000 of the Company’s own shares via the stock market by
March 31, 2009. Together with the shares currently held in treasury, MeVis
Medical Solutions may hold up to 10 percent of its own shares by the end of
this stock buy-back program.

By repurchasing its own shares, the Company wants to gain additional
strategic scope in the event of acquisitions, the purchase of intellectual
property, investments and similar transactions aimed at further
implementing its growth strategy. Unless these transactions can be realized
in the foreseeable future, the shares held by the Company in treasury can
also be cancelled.

The buyback is being executed by M.M. Warburg & CO in accordance with the
provisions of EU Regulation 2273/2003 of December 22, 2003 independently
and free of any influence on the part of the Company. In accordance with
the wording of the resolution passed by the shareholders at the annual
general meeting, the purchase price of the shares (excluding transactions
costs) must not be any more than five percent above or below the average
price at which the Company’s stock has been traded in the closing auction
of the Frankfurt stock exchange Xetra trading system on the five trading
days immediately preceding the acquisition.

Information on the progress of the stock buy-back program will be regularly
updated at MeVis Medical Solution AG’s website.
04.11.2008 Financial News transmitted by DGAP

---

Language: English
Issuer: MeVis Medical Solutions AG
Universitätsallee 29
28359 Bremen
Deutschland
Phone: +49 421 330 74-0
Fax: +49 421 330 74-50
E-mail: ir@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, München, Düsseldorf, Stuttgart

End of News DGAP News-Service

---